Your browser doesn't support javascript.
loading
Angiotensin-converting enzyme inhibition but not angiotensin II type 1 receptor antagonism augments coronary release of tissue plasminogen activator in hypertensive patients.
Matsumoto, Tetsuya; Minai, Kazuo; Horie, Hajime; Ohira, Naoto; Takashima, Hiroyuki; Tarutani, Yasuhiro; Yasuda, Yo; Ozawa, Tomoya; Matsuo, Shinro; Kinoshita, Masahiko; Horie, Minoru.
Affiliation
  • Matsumoto T; First Department of Internal Medicine, Shiga University of Medical Science, Seta Tsukinowa, Otsu, Japan. tetsuyam@belle.shiga-med.ac.jp
J Am Coll Cardiol ; 41(8): 1373-9, 2003 Apr 16.
Article in En | MEDLINE | ID: mdl-12706934
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bradykinin / Angiotensin-Converting Enzyme Inhibitors / Tissue Plasminogen Activator / Losartan / Coronary Circulation / Perindopril / Angiotensin Receptor Antagonists / Hypertension / Antihypertensive Agents Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Am Coll Cardiol Year: 2003 Document type: Article Affiliation country: Japan Country of publication: United States
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bradykinin / Angiotensin-Converting Enzyme Inhibitors / Tissue Plasminogen Activator / Losartan / Coronary Circulation / Perindopril / Angiotensin Receptor Antagonists / Hypertension / Antihypertensive Agents Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Am Coll Cardiol Year: 2003 Document type: Article Affiliation country: Japan Country of publication: United States